NodeGuardian

This article compares two State Street real estate ETFs: RWR, which targets U.S. REITs and is cost-efficient, and RWX, which offers international exposure but includes REOCs that may dilute income. Investors are advised to weigh domestic vs. international focus, costs, and income expectations.

Kahn Swick & Foti, LLC has alerted investors about a class action lawsuit against Gemini Space Station, Inc. for allegedly making misleading statements during its IPO. Affected investors can seek lead plaintiff status by May 18, 2026.

BofA Finance introduces Callable Yield Notes linked to Nike stock, offering a two-year term with a contingent coupon of at least 13.05% per annum. Investors risk principal loss if Nike's stock drops below 65% at maturity.

This article analyzes the Fidelity Solana Fund (FSOLON) for 2026-2030, focusing on market status and key technical indicators. It predicts a bearish trend for 2026, urging investors to integrate technical and fundamental analyses in their decisions.

Grainger has been named one of the 2026 World's Most Ethical Companies by Ethisphere for the second year in a row, highlighting its strong ethics and governance. This recognition supports Grainger's commitment to integrity and strengthens its brand strategy.

JPMorgan Chase & Co. raised its price target for Edgewise Therapeutics from $34 to $45, maintaining an "overweight" rating. Despite a recent EPS miss, analysts give a "Moderate Buy" rating, focusing on the company's precision medicines for rare diseases.

IHS Holding Limited reported a Q4 2025 net loss of $75.8 million despite increased sales. The $2.9 billion acquisition by MTN Group raises balance sheet concerns, emphasizing currency risks and debt, urging investors to reassess their outlooks.

Labcorp and Illumina are collaborating to improve precision oncology testing by developing IVD kits and genomic profiling tests, generating clinical evidence for payer coverage, and conducting a study on NSCLC samples to highlight the value of genomic profiling.

ResMed (NYSE:RMD) CEO Michael Farrell sold 4,991 shares of the company's stock on March 9th for over $1.25 million, reducing his stake by about 1.06%. This sale occurred shortly after ResMed reported stronger-than-expected quarterly earnings and declared a quarterly dividend. The stock currently

This article describes the product "3M Scotchbond 7423 Etchant Etching Gel" available from Henry Schein Dental. It is a specific dental etching gel manufactured by 3M and distributed by Henry Schein.

Williams-Sonoma, Inc. experienced a 4% drop in Q4 sales to $2.4 billion, yet comparable sales rose 3.2%. For fiscal year 2025, revenue increased to $7.8 billion, with a forecasted growth of 2.7% to 6.7% for fiscal year 2026.

The North Dakota Public Service Commission has authorized a 10.66% interim gas rate hike for Xcel Energy, starting April 1, leading to an $8.42 monthly increase for residential customers. A larger rate increase may follow.

Bristol Myers Squibb is tackling potential patent expirations by enhancing its research in oncology, immunology, cardiovascular diseases, and hematology, aiming to develop new therapies and maintain revenue.

Teledyne Technologies (TDY) has performed well with shares around $635.11, but some see it as 9.2% undervalued. Concerns arise over its high P/E ratio. A thorough analysis is recommended to weigh potential gains against valuation risks.

UBS Group increased its price target for Perspective Therapeutics to $8.00, retaining a "buy" rating. Despite weak fundamentals, the company shows positive clinical progress with its [212Pb]VMT‑α‑NET therapy, attracting institutional interest.

TD Cowen raised Devon Energy's price target to $50.00, keeping a "hold" rating, indicating a 5.96% upside. The company reported a quarterly EPS of $0.82, surpassing estimates, with a market cap of about $29.3 billion and a "Moderate Buy" consensus rating.

The article posits that APP is a better investment than Synopsys due to its lower valuation and higher growth in revenue and operating income, emphasizing the importance of multi-factor analysis in investment evaluations.

Seagate Technology's stock rose 3.88% thanks to strong financial results and positive market outlooks. The company benefits from a "storage supercycle" fueled by AI, with hard drive production sold out until 2026, despite minor volatility and selling.